Consider Ezetimibe as a Statin Add-On

July 2015

You'll continue to see LESS use of non-statins (niacin, etc) for dyslipidemia...due to limited evidence of CV benefit.

Consider discontinuing non-statins when patients are admitted if there's no good reason for the patient to be on them.

Use these tips to evaluate the need for non-statins.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote